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RECENTLY IN PRESSThe Wnt Transcriptional Switch: TLE Removal or
Inactivation?Aravinda-Bharathi Ramakrishnan, Abhishek Sinha, Vinson B. Fan,
and Ken M. Cadigan*Many targets of the Wnt/β-catenin signaling pathway are regulated by TCF
transcription factors, which play important roles in animal development, stem
cell biology, and oncogenesis. TCFs can regulate Wnt targets through a
“transcriptional switch,” repressing gene expression in unstimulated cells
and promoting transcription upon Wnt signaling. However, it is not clear
whether this switch mechanism is a general feature of Wnt gene regulation
or limited to a subset of Wnt targets. Co-repressors of the TLE family are
known to contribute to the repression of Wnt targets in the absence of
signaling, but how they are inactivated or displaced by Wnt signaling is
poorly understood. In this mini-review, we discuss several recent reports that
address the prevalence and molecular mechanisms of the Wnt transcription
switch, including the finding of Wnt-dependent ubiquitination/inactivation of
TLEs. Together, these findings highlight the growing complexity of the
regulation of gene expression by the Wnt pathway.1. Introduction
The Wnt pathway facilitates short-range signaling during
development and in adult tissues. It has important roles in
stem cell homeostasis and in the etiology of several cancers and
human diseases.[1,2] Transcriptional regulation by the Wnt
pathway begins with the stabilization and nuclear accumulation
of β-catenin.[3,4] This Wnt/β-catenin pathway (also known as
canonical Wnt signaling) regulates gene expression via recruit-
ment of β-catenin to Wnt-responsive cis-regulatory modules
(W-CRMs).[5] By far the best characterized family of transcription
factors that bind β-catenin and regulate W-CRMs belong to the
T-cell factor/lymphoid enhancer-binding factor 1 (TCF/LEF1)
family,[6] hereafter referred to as TCFs.
Shortly after the discovery that transcriptional activation byWnt
signaling was mediated by TCFs through direct binding to
β-catenin,[7–9] it was also recognized that TCFs have an additional
β-catenin-independent function: repression of Wnt target gene
expression in the absence of signaling. This realization came fromA-B. Ramakrishnan, Dr. A. Sinha, V. B. Fan, Prof. K. M. Cadigan
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Drosophila and Caenorhabditis elegans em-
bryos, loss of TCF activity can elevate Wnt
transcriptional readouts.[10–13] Second, char-
acterization of TCF regulation of the siamois
promoter in Xenopus blastomeres reveals
that TCF binding sites mediate both basal
repression and β-catenin-dependent activa-
tion of this element.[14,15] TCF repression of
Wnt target gene expression is important for
many aspects of animal development across
the evolutionary spectrum[11,12,16–18] and is
crucial for maintenance of embryonic stem
cells.[19–22] In addition, TCFs act as tumor
suppressors in colorectal cancer.[23,24] Given
the importance of basal TCF repression for
the proper regulation of Wnt target genes,
understanding the mechanism of this
repressionandhowβ-catenin convertsTCFs
to transcriptional activatorshasbeenamajor
focus of the field.A key insight into the mechanism of transcriptional inhibition
by TCFs was the finding that they can directly bind tomembers of
the transducin-likeenhancerofsplit (TLE) familyof transcriptional
co-repressors, and this association counteracts TCF/β-catenin
transactivation activity.[25,26] These observations favor a model of
dual regulation of Wnt targets by TCFs, TLEs, and β-catenin
(Figure 1). Targets of other signalingpathways (e.g., Ras andNotch
signaling), while regulated by different transcription factors and
co-regulators, nonetheless have a similar dual regulation, leading
to the idea of a “transcriptional switch” controlling the expression
of genes induced by signaling pathways.[27]
TLEsactwithmanyrepressive transcription factors inaddition to
TCFs.[28,29] TLEs form homotetramers through their N-terminal
“Q” domains and bind directly to histone deacetylases through the
adjacent (GP) domain (Figure 1A). Both interactions are thought to
contribute to the ability of TLEs to repress transcription.[30–33] In
addition, the C-terminal WD40 domain is implicated in nucleo-
some binding and condensation.[34] Drosophila have one TLE,
Groucho (Gro), which antagonizes signaling byWingless (Wg, afly
Wnt).[25,35,36] The Gro homolog UNC-37 plays a similar role in
C. elegans embryogenesis.[37] There are four TLEs in mammalian
genomes, alsoknownasGroucho relatedgenes (Grgs), alongwitha
fifth familymember lacking theWD40domainthat is thought toact
as a naturally occurring dominant negative.[38] Severalmammalian
TLEs have been linked to repression of Wnt target genes.[30,39–43]
In this mini-review we will discuss several recent reports that
revise the classic Wnt transcriptional switch model. These© 2017 WILEY Periodicals, Inc.
Figure 1. Traditional models of theWnt transcriptional switch. A) Domain architecture of the principal components of the switch, using human proteins
of each family as archetypes. Colored portions represent interaction domains: Q, glutamine-rich domain; GP, glycine/proline-rich domain; PHD, PHD
zinc finger domain; βBD, β-catenin binding domain; HMG, high mobility group; PBD, pygopus binding domain; HD1-3, homology domains 1–3. B) The
transcriptional switch model in invertebrates. In the absence of Wg signaling in Drosophila, Pan recruits Gro to W-CRMs and represses transcription.
When Wg signaling is activated, Gro is displaced and Arm binds to Pan, recruiting Lgs, Pygo, and other co-activators, which activate transcription. Lgs
acts as an adaptor between Arm and Pygo. C) The TCF switch model in vertebrate Wnt signaling. In the absence of Wnt signaling, repressive TCFs such
as TCF3 are bound to W-CRMs. TLEs likely play a role for repression of many targets. Upon Wnt stimulation, TCF3 is replaced by activating TCFs such as
TCF1, which recruit β-catenin and other co-activators. Some factors in panels (B) and (C) are depicted with dotted lines to highlight the likelihood that
they do not regulate all Wnt targets in their respective systems.
www.advancedsciencenews.com www.bioessays-journal.comreports address the importance of TLEs in repressing Wnt
targets, highlight new players and mechanisms by which Wnt
signaling inactivates TLE activity, and identify other factors that
may contribute to the transcriptional switch.2. Is the Transcriptional Switch a General
Feature of Wnt Gene Regulation?
Analysis of TCF mutants in several systems has provided
abundant evidence that they can antagonize Wnt gene
regulation.[6,40,44–48] Because vertebrates contain four or five
TCF genes, loss of function studies cannot easily address
whether all Wnt targets are repressed by TCFs, due to potential
redundancy. The situation is simpler in nematodes and flies,
which contain only one TCF gene. In these invertebrates, there
are examples where loss of TCF resulted in no detectable
derepression, that is, increase in expression of Wnt tar-
gets.[16,49] In addition, while some transcriptional reporters of
Wnt signaling are derepressed by the mutation of TCF binding
sites,[14,50,51] many others simply show a loss of Wnt-dependent
activation and no evidence of derepression.[52,53] However,
these reporters may not fully recapitulate all aspects of their
cognate gene’s expression. Thus, the fraction of Wnt targets
regulated by a switch-based mechanism remains an open
question.BioEssays 2018, 40, 1700162 1700162 (A recent paper addresses this question in Kc167 cells, a
Drosophila cell line commonly used to study Wg gene regulation.
Using CRISPR/Cas9 editing, the authors isolated cell lines
lacking Pangolin (Pan) or Armadillo (Arm), the fly TCF and
β-catenin, respectively.[54] RNAseq analysis identified 40 genes
activated by Wg treatment, all of which required both Arm
and Pan for activation. A fraction (37.5%) of these
displayed significant depression when Pan was absent in
unstimulated cells.[54] This data set reinforces the view that
TCF-mediated repression of Wnt targets in the absence of Wnt
signaling is common, but not universally observed (Figure 2A).
One caveat of this study is the possibility of other repressive
mechanisms acting redundantly with TCF in this system. For
example, the Wnt target naked cuticle (nkd) was derepressed by
RNAi depletion of Pan or Gro. Additional depletion of the co-
repressor CtBP with Pan or Gro resulted in a synergistic
derepression.[35] It would be interesting to see whether the 62.5%
ofWnt targets identifiedbyFranzet al.[54] that arenotderepressedby
Pan depletion are sensitive to simultaneous loss of Pan and CtBP.3. Does Activation of Wnt Signaling Lead to
Displacement of TLEs from W-CRMs?
How important are TLEs in regulating Wnt targets? While there
are several examples of derepression of Wnt target gene© 2017 WILEY Periodicals, Inc.2 of 6)
Figure 2. Emerging complexities in Wnt target gene regulation covered in
this mini-review. A) As described by Franz et al.,[54] many Wnt target genes
show no evidence of TCF/Pan dependent repression in the absence of
Wnt signaling. B) Model proposed in van Tienen et al.,[60] where in the
absence of Wnt signaling, TLE, BCL9/B9L, and Pygo proteins co-occupy
W-CRMs. C) This model postulated that these factors are also associated
with TCF in Wnt-stimulated cells, along with β-catenin and other co-
activators. There is also evidence that TLEs are inactivated by
ubiquitination via UBR5 (not shown).[42] In addition, newly discovered
negative regulatory elements (NREs) are proposed to be bound by TCFs
and β-catenin, repressing transcription uponWnt stimulation, fine-tuning
the transcriptional response of traditional W-CRMs.[76] Each of these
models have important considerations. The work of Franz et al. is limited
to a single Drosophila cell line, while the “TCF complex reconfiguration”
model of van Tienen et al. is based on complex composition in solution,
not onW-CRM chromatin. The extent of UBR5modification of TLEs, while
evolutionarily conserved, requires further study, as does the functional
importance of NREs in regulating Wnt targets. See text for further
comment.
www.advancedsciencenews.com www.bioessays-journal.comexpression in Drosophila gro mutants,[25,35,36,42] the functional
evidence implicating these co-repressors in vertebrate systems is
largely based on overexpression.[40,43] However, ChIP-seq data
from early Xenopus gastrulae, reveals an 86% correlation
between β-catenin and TLE-bound sites.[55] Similarly, in mouse
hair follicle stem cells, more than half the genes occupied by
TCFs are also occupied by TLEs.[40] These studies suggest that
TLE-regulation of Wnt targets is widespread.
From the time of the initial discovery of TLEs as repressors of
Wnt target gene expression, it has been attractive to propose that
theWnt transcriptional switch ismediated by β-catenin displacing
TLEs on TCFs (Figure 1B,C). In support of this model, ChIP
studies indicate a Wnt signaling-dependent loss of TLE fromBioEssays 2018, 40, 1700162 1700162 (W-CRMs regulating c-myc and cyclin D2 expression.[41,56] In
addition, biochemical experiments suggest that β-catenin and
TLE1binding toTCFs aremutually exclusive,[57] but this result has
been challenged by more recent results from the same lab, which
found that TCF can bind both proteins simultaneously.[39] At
present, there is insufficient evidence to fully support β-catenin
displacement of TLEs from W-CRMS as a general model.
A corollary of the switch model is that β-catenin recruits
transcriptional co-activators to W-CRMs.[46] One such co-
activator complex is a heterodimer consisting of B-cell CLL/
lymphoma 9 (Bcl9 or the related B9L—known as Legless or Lgs
in flies) and Pygopus 1/2 (Pygo). Several studies have
demonstrated the existence of a trimeric complex, with the
HD1 domain of Bcl9 bound to β-catenin and the HD2 domain to
Pygo.[5,58,59] Interestingly, Pygo also associates with Gro in flies,
and analysis of gro, pygo double mutants suggests that a major
function of Pygo is to inactivate Gro.[36] A recent study[60]
examined proteins associated with biotin ligase-tagged BCL9
and B9L, in the presence and absence of Wnt signaling using a
technique called BioID. Surprisingly, the authors found both
BCL9 and B9L associated with TLEs irrespective of the state of
Wnt signaling in HEK293 cells. Their co-immunoprecipitation
experiments also indicate that BCL9/B9L and TCF are a part of
the same complex even in the absence of Wnt signaling. Similar
results were obtained when Pygo was used. The authors argue
that rather that stimulating an exchange of co-regulators, the
addition of β-catenin causes a change in the conformation of the
TCF transcriptional complex (Figure 2B,C).[60]
The results of van Tienen et al. challenge the β-catenin
displacement of TLE model, but some caution is needed, as the
BioID and co-IP methodology utilized do not distinguish
between complexes in solution and those onW-CRM chromatin.
Further ChIP experiments, preferably at the genomic level, will
be needed to fully test whether TLE displacement or
conformational change of the TCF transcriptional complex is
the major mechanism by which the transcriptional switch
occurs.4. Wnt-Dependent Ubiquitination of TLEs
Regulates the Transcriptional Switch
If β-catenin does not simply displace TLEs at W-CRMs, how does
Wnt signaling inactivate these co-repressors? Another recent
report from the Flack et al.[42] offers an intriguing mechanism.
They found that the E3 ubiquitin-protein ligase UBR5 (UBR5) is
required for efficient Wnt signaling in HEK293 cells. In
Drosophila, cells lacking the UBR5 homolog hyperplastic discs
(hyd) displayed a classic loss of Wg signaling in wing imaginal
discs. UBR5/Hyd functioned downstream of β-catenin stabili-
zation. A mass-spectrometry screen identified an interaction
between UBR5 and TLE3, and UBR5 ubiquitinated TLE3 on its
C-terminal WD40 domain.[42] Activation of Wnt/β-catenin
signaling stimulated UBR5 ubiquitination of TLE3. In flies,
the hyd phenotype is partially suppressed by concomitant loss of
gro, indicating that TLE/Gro is a major target of Hyd action.
Taken together, these results strongly support a model where
activation of UBR5 by Wnt signaling inactivates TLEs through
ubiquitination.[42]© 2017 WILEY Periodicals, Inc.3 of 6)
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modification that is commonly thought to target proteins for
proteasomal degradation.[61] However, Flack et al.[42] found no
evidence for UBR5/Hyd regulation of TLE3/Gro protein levels or
turnover. Rather, they demonstrated that the AAAþ ATPase
Valosin-containing protein (VCP, also known as p97) bound to
and reduced the level of ubiquitinated TLE3 in Wnt stimulated
cells. Genetic or chemical inhibition of VCP/p97 reduced Wnt
gene activation.[42] The authors suggest that VCP/p97, which is
thought to unfold ubiquitinated proteins via its ATPase
activity,[62] disrupts the tetramerization of ubiquitinated TLE3,
which is required for its ability to repress Wnt targets.[39]
This work fills an important gap in our understanding of the
interactions between the Wnt signaling machinery and TLEs,
but additional mechanisms may also exist. For example, Hanson
et al. reported that the E3 ubiquitin ligase X-linked Inhibitor of
Apoptosis (XIAP) bound and mono-ubiquitinated TLE3 at its
N-terminal Q domain. This modification disrupted TCF4-TLE3
binding.[63] XIAP was recruited to an Axin2 W-CRM upon Wnt
stimulation. XIAP knockdown via siRNA in mammalian cell
culture or via morpholinos in Xenopus embryos greatly reduced
Wnt/β-catenin signaling.[63] It should be noted that XIAPmutant
mice are viable and do not exhibit detectable Wnt signaling
defects[64] and CRISPR/Cas9 knockout of XIAP in HEK293 cells
displayed a modest effect on a Wnt reporter compared to UBR5
knockouts.[42] Nonetheless, given that UBR5 and XIAP modify
TLE3 in distinct ways (poly vs. mono-ubiquitination) and at
different locations on the primary TLE3 sequence, the possibility
exists that the two E3 ligases act independently to inactivate TLE
activity at W-CRMs. Further research, including examining the
phenotype of UBR5, XIAP double knockouts on a variety of Wnt
readouts, should help to clarify their respective roles in
mediating the Wnt transcriptional switch.5. Is TCF3 a Dedicated Repressor in the
Transcriptional Switch?
While invertebrates contain one TCF, which participates in both
sides of the transcriptional switch (Figure 1B),[46] the presence of
multiple TCFs in vertebrates has long raised the question of
whether they have specialized transcriptional functions. Many
genetic studies support the view that TCF3 (also known as
TCF7L1) is a dedicated repressor and LEF1 a dedicated activator
of Wnt targets, while TCF1 and TCF4 (also termed TCF7 and
TCF7L2, respectively) display either activity depending on the
context.[1,6,65] Partially supporting this, TCF3 and TCF4 bind to
TLEs with higher affinity than LEF1 or TCF1.[39] In support of a
“TCF exchange” model (Figure 1C), TCF3 is removed from
W-CRMs via Wnt-dependent phosphorylation[66,67] or down-
regulation of its expression.[18,19,68]
One model for investigating the relationship between Wnt
signaling and TCF3 are mouse embryonic stem cells (mESCs).
TCF3 is the most abundantly expressed TCF in mESCs, where it
limits self-renewal through repression of pluripotency genes.[19–22]
TCF3 expression and/or function is inhibited by activation ofWnt/
β-catenin signaling.[18,19,22,68] TCF3 andTCF1havebeen reported to
haveopposingactivities inmESCs, consistentwithTCF3repressing
and TCF1 activating the same transcriptional targets.[69]BioEssays 2018, 40, 1700162 1700162 (The antagonistic relationship between TCF1 and TCF3 has
been challenged by recent work fromMoreira et al.[70] They used
CRISPR/Cas9 to knockout all four TCF genes in mESCs. While
proliferation of these quadruple knockouts (QKO) was unaf-
fected, the activation of Wnt reporters was negligible. When
subjected to differentiation conditions, QKO cells could not form
mesendoderm andwere biased toward neurectoderm formation.
Interestingly, this defect could be rescued by knocking in cDNAs
of TCF1 or TCF3 at their endogenous loci. Transcriptome
profiling of the QKOs and their rescues revealed that the
expression profiles of both TCF1 and TCF3 rescued QKOs were
similar to each other and were more similar to WTmESCs than
the QKO cells.[70]
The results of Moreira et al. are at odds with the literature that
TCF3 is predominately/exclusively a repressor, but these studies
are based on removal of TCF3 in genetic backgrounds where the
other three TCFs are present. Perhaps in the QKO/rescue
experiments, TCF3 is capable of mediating both sides of the
transcriptional switch, taking over the activating function
normally carried out by other TCFs. It should be noted that
TCF3 does mediate β-catenin-dependent transcriptional activa-
tion in overexpression assays.[9,71,72] It would be interesting to
examine whether TCF3 can rescue the developmental pheno-
types of other TCFs[71,73] during mouse embryogenesis if it was
the sole TCF expressed.6. Other Potential Factors Acting in the Switch
In addition to TCFs, TLEs, β-catenin, and UBR5, there are many
other nuclear factors that have been proposed to contribute to the
Wnt transcriptional switch,[46] and more factors continue to be
identified. For example, O-GlcNAc Transferase (OGT) has been
reported to promote TLE repression by direct interaction with
TLEs, and this interaction was attenuated by Wnt signaling in
mammalian cell culture.[56] The transcription factor Ladybird
homeobox 2 (Lbx2) activated Wnt transcriptional readouts in
zebrafish by binding to the WD40 domain of TLEs, blocking
their ability to bind to TCFs.[74] In another recent report, the
selenoenzyme Glutathione peroxidase 4 (GPX4) was shown to
bind to TCFs and prevent their association with chromatin. The
Wnt antagonistic functions of GPX4 were independent of its
catalytic activity.[75] Whether these factors are tissue/cell specific
regulators or more broadly required for Wnt transcriptional
regulation requires further study.
While these trans-acting factors add more complexity to the
Wnt gene regulatory circuit, a new cis-regulatory motif
influencing W-CRMs was also recently reported. An 11 bp motif
(termed a negative regulatory element, or NRE) was identified
upstream of the siamois promoter, a previously characterized
direct Wnt target gene.[76] The NRE represses siamois expression,
and was specifically bound by TCF in vitro. Similar motifs were
identified upstream of a W-CRM regulating expression of the
T (Brachyury) gene in mouse embryonic stem cells, and
removing them via CRISPR/Cas9 caused an increase in TmRNA
levels.[73,76]
NREs have a different consensus than traditional TCF sites, in
that way evoking the WGAWAW sites identified in genes
repressed by Wnt/β-catenin signaling in fly hematopoietic cells© 2017 WILEY Periodicals, Inc.4 of 6)
www.advancedsciencenews.com www.bioessays-journal.com(Figure 2C).[77,78] β-catenin was detected near the NREs in the
T and siamois promoters using ChIP,[76] but whether or not
β-catenin regulates gene expression at those locations remains to
be determined. Computationally, NREs are enriched near
W-CRMs, suggesting that they may be a common feature of
Wnt gene regulation.[76]7. Conclusions and Outlook
While probably not universal, the transcriptional switch model
appears to contribute to the regulation of many Wnt/TCF targets,
although more functional studies in vertebrate systems would
strengthen this claim. Basicmechanistic features of the switch are
yet to be clarified, most notably whether Wnt/β-catenin signaling
promotes anexchangeof factors atW-CRMsor a rearrangement of
their configuration. It is also possible that differentWnt targets are
regulated by distinct switch mechanisms, and all of the factors
discussed in this review likely only regulated a subset of Wnt
targets. While the field’s ability to genetically manipulate switch
components is at an unprecedented level thanks to CRISPR/Cas9
editing, a lack of ChIP-quality antibodies for many of the key
factors is limiting our understanding of what is happening on the
chromatin. As these reagents are developed, further investigation
of the regulation of biologically important genes, as well as
genome-wide studies should provide a greater understanding of
how β-catenin alters the transcriptional complexes regulatingWnt
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